NCT05451212 2025-11-10Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia GravisCabaletta BioPhase 1 Completed7 enrolled
NCT06381284 2025-03-25Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-AssessmentZS AssociatesCompleted215 enrolled
NCT04176211 2024-06-03The Impact of Myasthenia Gravis in the Real WorldVitaccess LtdCompleted2,847 enrolled